Florence Parent

Inserm — France

Medicine · Health Sciences

55h-index16.1kcitations257works8.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pulmonary Hypertension Research and Treatments(107), Venous Thromboembolism Diagnosis and Management(74), Atrial Fibrillation Management and Outcomes(31), Vascular Anomalies and Treatments(21), Cardiovascular Issues in Pregnancy(19)

Publications252 total

Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) after pulmonary embolism (PE): PREVA-CTEPH study
2025
Cardiopulmonary hemodynamic determinants of long-term survival in sickle cell disease: insights from the ETENDARD study
2025
Cardiopulmonary Hemodynamic Determinants of Long-Term Survival in Sickle Cell Disease: Insights from the ETENDARD Study
American Journal of Respiratory and Critical Care Medicine·2025Open Access
Stratégie diagnostique d’une masse du médiastin
Encyclopédie médico-chirurgicale. Pneumologie·2025
Role of the HGF/c-MET pathway in resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer
Cancer Immunology Immunotherapy·2025· 4 citedOpen Access
Le paradoxe du pilotage à l'usage des chefs de groupement pour une réussite de l'action collective : Quels outils sont vraiment adaptés et comment les cadres les prennent-ils en compte pour les exploiter au quotidien malgré l'environnement incertain des SIS ? [ensosp]
SPIRE - Sciences Po Institutional REpository·2024Open Access
Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer
Lung Cancer·2023· 6 citedOpen Access
1496P Higher levels of CSF-1 support resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer
Annals of Oncology·2023Open Access
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial
EClinicalMedicine·2023· 15 citedOpen Access
Functional respiratory complaints among COVID-19 survivors: a prospective cohort study
ERJ Open Research·2023· 17 citedOpen Access
Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studies
Journal of Thrombosis and Haemostasis·2022· 17 citedOpen Access
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study
The Lancet Respiratory Medicine·2022· 205 cited
Erythrocytes are altered in pulmonary arterial hypertension
European Respiratory Journal·2022· 1 cited
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation
Annals of Internal Medicine·2021· 69 citedOpen Access
Frequency and risk factors for Chronic Thromboembolic Pulmonary Hypertension after a first unprovoked Pulmonary Embolism: results from PADIS-studies
2021· 1 cited
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine·2021· 188 cited
Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment
European Respiratory Journal·2021· 11 citedOpen Access
Fully Integrated Quantitative Multiparametric Analysis of Non–Small Cell Lung Cancer at 3-T PET/MRI
Clinical Nuclear Medicine·2021· 9 cited
BPA and Riociguat for the Management of Inoperable CTEPH: Results of the Extension Study Following the RACE Randomized Controlled Trial (RCT)
2021· 10 citedOpen Access
Screening for Pulmonary Arterial Hypertension in Adults Carrying a BMPR2 Mutation
2021· 6 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Gérald Simonneau(35), Olivier Sitbon(29), Marc Humbert(27), Xavier Jaïs(19), Laurent Savale(19), David Montani(17), Philippe Hervé(15), Guy Meyer(9), Olivier Sanchez(9), Françis Couturaud(8), Philippe Girard(7), Mitja Jevnikar(7), Athénaïs Boucly(5), Edmund Lau(5), Élie Fadel(5), Florent Soubrier(5), R. Azarian(5), Andrei Seferian(5), Hilario Nunès(4), Jason Weatherald(4)